BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23287475)

  • 1. The involvement of a Nanog, Klf4 and c-Myc transcriptional circuitry in the intertwining between neoplastic progression and reprogramming.
    Marzi I; Cipolleschi MG; D'Amico M; Stivarou T; Rovida E; Vinci MC; Pandolfi S; Dello Sbarba P; Stecca B; Olivotto M
    Cell Cycle; 2013 Jan; 12(2):353-64. PubMed ID: 23287475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gata4 blocks somatic cell reprogramming by directly repressing Nanog.
    Serrano F; Calatayud CF; Blazquez M; Torres J; Castell JV; Bort R
    Stem Cells; 2013 Jan; 31(1):71-82. PubMed ID: 23132827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GATA5 inhibits hepatocellular carcinoma cells malignant behaviours by blocking expression of reprogramming genes.
    Feng H; Zhu M; Zhang R; Wang Q; Li W; Dong X; Chen Y; Lu Y; Liu K; Lin B; Guo J; Li M
    J Cell Mol Med; 2019 Apr; 23(4):2536-2548. PubMed ID: 30672133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell fate determination factor Dachshund reprograms breast cancer stem cell function.
    Wu K; Jiao X; Li Z; Katiyar S; Casimiro MC; Yang W; Zhang Q; Willmarth NE; Chepelev I; Crosariol M; Wei Z; Hu J; Zhao K; Pestell RG
    J Biol Chem; 2011 Jan; 286(3):2132-42. PubMed ID: 20937839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spermatogonial stem cells and progenitors are refractory to reprogramming to pluripotency by the transcription factors Oct3/4, c-Myc, Sox2 and Klf4.
    Corbineau S; Lassalle B; Givelet M; Souissi-Sarahoui I; Firlej V; Romeo PH; Allemand I; Riou L; Fouchet P
    Oncotarget; 2017 Feb; 8(6):10050-10063. PubMed ID: 28052023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic regulation of pluripotent genes mediates stem cell features in human hepatocellular carcinoma and cancer cell lines.
    Wang XQ; Ng RK; Ming X; Zhang W; Chen L; Chu AC; Pang R; Lo CM; Tsao SW; Liu X; Poon RT; Fan ST
    PLoS One; 2013; 8(9):e72435. PubMed ID: 24023739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reprogramming bladder cancer cells for studying cancer initiation and progression.
    Iskender B; Izgi K; Canatan H
    Tumour Biol; 2016 Oct; 37(10):13237-13245. PubMed ID: 27456363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Versatile In Vivo System to Study Myc in Cell Reprogramming.
    Senís E; Mosteiro L; Grimm D; Abad M
    Methods Mol Biol; 2021; 2318():267-279. PubMed ID: 34019296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis.
    Yu D; Thomas-Tikhonenko A
    Oncogene; 2002 Mar; 21(12):1922-7. PubMed ID: 11896625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A feedback loop comprising PRMT7 and miR-24-2 interplays with Oct4, Nanog, Klf4 and c-Myc to regulate stemness.
    Lee SH; Chen TY; Dhar SS; Gu B; Chen K; Kim YZ; Li W; Lee MG
    Nucleic Acids Res; 2016 Dec; 44(22):10603-10618. PubMed ID: 27625395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular coupling of Tsix regulation and pluripotency.
    Navarro P; Oldfield A; Legoupi J; Festuccia N; Dubois A; Attia M; Schoorlemmer J; Rougeulle C; Chambers I; Avner P
    Nature; 2010 Nov; 468(7322):457-60. PubMed ID: 21085182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression Nanog activates pluripotent genes in porcine fetal fibroblasts and nuclear transfer embryos.
    Zhang L; Luo YB; Bou G; Kong QR; Huan YJ; Zhu J; Wang JY; Li H; Wang F; Shi YQ; Wei YC; Liu ZH
    Anat Rec (Hoboken); 2011 Nov; 294(11):1809-17. PubMed ID: 21972213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posttranslational modifications of defined embryonic reprogramming transcription factors.
    Ramakrishna S; Kim KS; Baek KH
    Cell Reprogram; 2014 Apr; 16(2):108-20. PubMed ID: 24568610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
    Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
    Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype.
    Li Y; Li A; Glas M; Lal B; Ying M; Sang Y; Xia S; Trageser D; Guerrero-Cázares H; Eberhart CG; Quiñones-Hinojosa A; Scheffler B; Laterra J
    Proc Natl Acad Sci U S A; 2011 Jun; 108(24):9951-6. PubMed ID: 21628563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manipulation of KLF4 expression generates iPSCs paused at successive stages of reprogramming.
    Nishimura K; Kato T; Chen C; Oinam L; Shiomitsu E; Ayakawa D; Ohtaka M; Fukuda A; Nakanishi M; Hisatake K
    Stem Cell Reports; 2014 Nov; 3(5):915-29. PubMed ID: 25418733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of pluripotent stem cell reprogramming factors by prostate tumor initiating cells.
    Bae KM; Su Z; Frye C; McClellan S; Allan RW; Andrejewski JT; Kelley V; Jorgensen M; Steindler DA; Vieweg J; Siemann DW
    J Urol; 2010 May; 183(5):2045-53. PubMed ID: 20303530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Klf4 transcription factor is expressed in the cytoplasm of prostate cancer cells.
    Le Magnen C; Bubendorf L; Ruiz C; Zlobec I; Bachmann A; Heberer M; Spagnoli GC; Wyler S; Mengus C
    Eur J Cancer; 2013 Mar; 49(4):955-63. PubMed ID: 23089465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hedgehog signaling and the Gli code in stem cells, cancer, and metastases.
    Ruiz i Altaba A
    Sci Signal; 2011 Nov; 4(200):pt9. PubMed ID: 22114144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functionality and transduction condition evaluation of recombinant Klf4 for improved reprogramming of iPS cells.
    Tang Y; Lin CJ; Tian XC
    Cell Reprogram; 2011 Apr; 13(2):99-112. PubMed ID: 21473687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.